within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03A_HormonalContraceptivesForSystemicUse.G03AB06_GestodeneAndEthinylestra;

model GestodeneAndEthinylestra
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.99,
    Cl = 1.1277777777777778e-05,
    adminDuration = 600,
    adminMass = 0.075 / 1000000,
    adminCount = 1,
    Vd = 0.0065,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.035,
    Tlag = 10.200000000000001,
    Vdp = 0.0025,
    k12 = 1.9444444444444442e-05,
    k21 = 1.9444444444444442e-05);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>GestodeneAndEthinylestradiol</td></tr><tr><td>ATC code:</td><td>G03AB06</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>0.075</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>6.5</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.58</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Gestodene and ethinylestradiol are components of a combined oral contraceptive pill used for birth control in women. The combination is widely used and approved for the prevention of pregnancy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy adult women after a single oral administration of one tablet containing 0.075 mg gestodene and 0.03 mg ethinylestradiol.</p><h4>References</h4><ol><li><p>Kuhnz, W (1990). Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to women. <i>American journal of obstetrics and gynecology</i> 163(6 Pt 2) 2120–2127. DOI:<a href=\"https://doi.org/10.1016/0002-9378(90)90551-h\">10.1016/0002-9378(90)90551-h</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2124087/\">https://pubmed.ncbi.nlm.nih.gov/2124087</a></p></li><li><p>Bergink, W, et al., &amp; Qvist, I (1990). Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin. <i>American journal of obstetrics and gynecology</i> 163(6 Pt 2) 2132–2137. DOI:<a href=\"https://doi.org/10.1016/0002-9378(90)90553-j\">10.1016/0002-9378(90)90553-j</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2147817/\">https://pubmed.ncbi.nlm.nih.gov/2147817</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.G.G03AB06 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end GestodeneAndEthinylestra;
